insights_auto
Why is ALPMF up 4.05%?
Dive Deeperchevron_right
ALPMF:OTCMKTS
Astellas Pharma Inc
$15.93
arrow_upward
+4.05%(+0.62) 1D
Sep 23, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALPMF...
Open
$15.93
High
$15.93
Low
$15.93
Mkt. cap
4.28T
Avg. vol.
909.00
Volume
467.00
52-wk high
$17.85
52-wk low
$9.85
Beta
-5.28
Shares outstanding
1.81B
No. of employees
14K
Open
$15.93
High
$15.93
Low
$15.93
Mkt. cap
4.28T
Avg. vol.
909.00
Volume
467.00
52-wk high
$17.85
52-wk low
$9.85
Beta
-5.28
Shares outstanding
1.81B
No. of employees
14K
News stories
From web sources and news partners
Crain's Chicago Business
·
6 hours ago
Drugmaker Astellas looks to sell U.S. headquarters in Northbrook
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com